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Abstract MS73, an ATPase regulatory subunit of the 26S 
proteasome in the moth Manduca sexta, is shown to be expressed 
at a high level only in muscles that are undergoing developmen-
tally programmed cell death, or which are destined to do so. The 
amount of MS73 is increased by more than two-fold just before 
death in each of three different muscles that die at different 
times, under different developmental controls. An ecdysteroid 
(moulting hormone) agonist, RH-5849, that prevents the 
occurrence of programmed cell death in two of these muscles 
also prevents the normally occurring rise in level of MS73 in 
these muscles. This evidence is consistent with a role for MS73 in 
programmed cell death. 
Key words: Proteasome; ATPase; Programmed cell death; 
Manduca sexta; Ecdysteroid agonist; RH-5849 
1. Introduction 
Evidence is now mounting that intracellular proteolysis is 
involved in programmed cell death [I]. In this paper we pre-
sent evidence that a regulatory ATPase subunit of the 26S 
proteasome may have a role in the programmed death of 
insect muscle during metamorphosis. 
The ventral intersegmental muscles of abdominal segments 
3-6 (ISM3-6) of the tobacco hornworm moth, Manduca sex-
ta, which are retained from the larval condition through the 
3-week pupal stage, are used during the emergence (eclosion) 
of the adult moth from the pupal case, but then degenerate 
and die. The muscles begin to regress in the ca. 48 h period 
prior to eclosion, a change dependent on the pre-emergence 
decline in titre of the insect's ecdysteroid moulting hormone, 
20-hydroxyecdysone, and then abruptly regress during the ca. 
36 h following eclosion [2]. These muscles have recently been 
extensively investigated as a model of developmentally pro-
grammed cell death (e.g. [3-7]), although the manner in which 
this death occurs can be distinguished from the typical apop-
tosis of mammalian cells in a number of ways [8]. 
We have previously shown [3] that MS73, a 47 kDa ATPase 
subunit of the 26S proteasome, is expressed in these muscles 
in a way that suggests an association with the developmentally 
programmed degeneration and death of these cells. The evi-
dence for this is as follows: 
A cDNA clone encoding MS73 was isolated from a library 
made from ISM3-6 mRNA at stage 7 of pharate (pre-emer-
gence) adult development. This is a stage at which the ISM 
are already regressing, and are preparing to die when the 
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moth ecloses. MS73 mRNA was found to be present in pha-
rate adult ISM3-6 at a low but detectable level prior to stage 
4 (about 68 h before eclosion) when there was an abrupt 
increase in expression. Western blotting showed that the 
amount of MS73 protein increased from stage 4 onwards, 
notably at stages 7 (about 6 h before eclosion) and 8 (time 
of eclosion). MS73 was identified as a part of the 26S protea-
some complex by its inferred amino acid sequence, which 
shows homology to other proteasome ATPases, and also by 
its presence in a very high molecular weight fraction isolated 
from ISM3-6 by glycerol gradient centrifugation. This frac-
tion possessed the multiple proteinase activities expected of 
the 26S proteasome, and could be distinguished from the 
smaller 20S proteasome which lacks the regulatory 19S 
'caps' [9]. 
MS73 is only one of a number of 26S proteasome subunits 
[9]. We have recently shown [10] that in addition to MS73, at 
least three other presumed regulatory 26S proteasome sub-
units with ATPase domains, and one non-ATPase subunit, 
also appear at higher levels in ISM3-6 just before the time 
of eclosion than at earlier stages. Moreover, Jones et al. [5] 
have independently shown that changes also occur in the pro-
teasome's multicatalytic proteinase core (20S proteasome) in 
this tissue at the same time. 
The possible role of 26S pro teas orne regulatory subunits in 
the programmed cell death of insect muscle is of considerable 
interest, since it has recently been shown that specific inhibi-
tors of proteasome proteinase activity can prevent the death 
of thymocytes exposed to inducers of apoptosis [11], and 
NGF-deprived sympathetic neurons [12] implying that protea-
some activation may also play an important role in 'typical' 
apoptotic events. 
To investigate further the possible association between 
MS73 and programmed cell death, we have studied the occur-
rence of MS73 in other tissues of the insect, including muscles 
that undergo programmed cell death at different times, and 
how these levels of MS73 change during development. We 
have also examined the effect of hormonal treatments on 
MS73 expression and programmed cell death. 
2. Materials and methods 
2.1. Insects 
Tobacco hornworms, Manduca sexta (L.) (Lepidoptera; Sphingi-
dae) were reared at 25°C, under a 17 h light-7 h dark photoperiod, 
on a wheat germ-based artificial diet using standard procedures [13]. 
Different stages of pharate adult development were recognised by a 
staging scheme adapted from that of Schwartz and Truman [2] and 
described fully in [14]. Briefly, stages of development mentioned in 
this paper are as follows: L5d4:feeding stage of the fifth instar, where 
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the first day after ecdysis from the fourth stage is designated dO; WO: 
the 24 h period following the occurrence of wandering (when the 
insect ceases to feed); WI (etc.): the days following WO; PO: the 
24 h period following pupal ecdysis; PI (etc.): the days following 
PO; pharate adult stage 0: greater than 100 h before ec1osion; pharate 
adult stage 3: about 80 h before ec1osion; pharate adult stage 7: 
about 6 h before eclosion; stage 8: eclosion ± 0.5 h; stage 8+ 15 h: 
15 ± 0.5 h after eclosion. 
2.2. Experimental treatments and tissue sampling 
The ecdysteroid agonist RH-5849 (kindly given by Dr G. Carlson, 
Rohm and Haas Co., Spring House, PA, USA) was injected (10 /.lg) in 
10 /.ll of ethanol into the lateral dorsal thorax of the insect using a 
Hamilton syringe with a fixed 28 swg needle. Control insects received 
10 /.ll ethanol alone. Tissue samples taken from insects were dissected 
under a simple insect saline solution [15], immediately frozen on a 
metal surface cooled with liquid nitrogen, and kept at -70°C until 
needed. 
Tissue samples were ground in a glass-glass homogeniser in TBS (20 
mM TRIS, 0.05 M NaCI, pH 7.5) and briefly centrifuged (3 min, 
12500 X g). The protein content of the supernatant was determined 
by the Bradford dye-binding method [16] using a BIO-RAD kit. 
2.3. Antibodies 
Polyclonal antiserum was generated against an N-terminal fusion 
protein of MS73 [3]. It was affinity purified by adsorption to N-ter-
minal fusion protein linked to an N-hydroxysuccinimide (NHS)-acti-
vated Sepharose column (Pharmacia Hi-Trap). 
2.4. Polyacrylamide gel electrophoresis and immunoblotting 
Tissue extracts were dissolved in Laemmli buffer and boiled for 
5 min. Polypeptides were separated on 10% SDS-polyacrylamide 
gels as described by Laemmli [17] using a Mini-PROTEAN II appa-
ratus (BIO-RAD). An amount of extract equivalent to 10 /.lg total 
protein was loaded in each lane. After electrophoresis the separated 
polypeptides were transferred electrophoretically onto Hybond-C 
super nitrocellulose membranes (0.45 /.lm, Amersham) and developed 
according to Towbin et al. [18]. 
The immunodetection of MS73 proteasome subunits was carried 
out using the affinity purified antibodies described above. Primary 
antibodies were visualised with a secondary anti-rabbit antibody la-
belled with alkaline phosphatase (Sigma) for development with the 
BCIP/NBT liquid substrate system (Sigma). 
2.5. Analysis of immunoblots 
Digital images of the stained immunoblots were acquired using an 
Epson desk scanner and a Macintosh computer, and manipulated 
using Adobe Photoshop. Individual bands were quantified by multi-
plying area X mean density. We verified in a separate experiment (not 
shown) that this measure of band intensity varied in a linear fashion 
with varying amounts of protein. The values obtained were used to 
calculate changes in the levels of MS73 relative to stage 8+ 15 h ISM3-
6 which was arbitrarily assigned as 100%. 
3. Results 
3.1. Tissue distribution of MS73 
An affinity purified antibody directed against the N-ter-
minal MS73 fusion protein labelled only a single sharp band 
at 47 kDa in immunoblots of TBS-soluble protein from a 
range of tissues (Fig. I). MS73 was present at high level 
only in extracts of intersegmental muscle (ISM3-6). Since an 
equal amount of total protein was loaded in each lane, band 
intensity, estimated from the product of area and mean den-
sity of staining, is taken to indicate the relative level of MS73 
in each tissue. 
As previously observed [3], MS73 levels in ISM3-6 changed 
dramatically during pre-emergence adult development, being 
present at high level only during the later stages of prepara-
tion for eclosion and after this event. Levels of the protein did 
not change appreciably with developmental stage in the other 
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Fig. 1. MS73 protein in a range of tissues in pharate adult Manduca 
sexta. A: Immunoblots of SDS-polyacrylamide gels. 10 /.lg of total 
TBS-soluble protein was loaded in each well. B: Quantitative esti-
mates of the amounts of MS73 in each of the tissues obtained from 
digital images of the bands shown in A. The stages shown are stage 
0, about 100 h before adult emergence; stage 7, about 6 h before 
adult emergence; stage 8+ 15 h, about 15 h after emergence. ISM3-6 
regresses during stage 7 and dies in the 36 h following eclosion. 
(lSM3-6: abdominal intersegmental muscle segments 3-6; FM: 
flight muscle; FB: fat body; VNC: ventral nerve cord; B: brain; 
T: testis; G: midgut; MT:- Malpighian tubules). 
tissues examined. Fig. I shows that MS73 was present at 
similar low levels in most of the tissues examined (flight mus-
cle, fat body, ventral nerve cord, brain and midgut) at pharate 
adult stages 0 and 7 and also in adult insects that had emerged 
15 h previously (stage 8+ 15 h). The levels of MS73 were some-
what higher in testis (T) and Malpighian tubules (MT, excre-
tory organs), but these were much lower than in ISM3-6, and 
did not change with development in the range of stages ex-
amined. The level of MS73 in ISM3-6 was 2.4 X higher at 
stage 7 than at stage O. The level of MS73 increased only 
slightly during the period between stage 7 and stage 8+ 15 h. 
3.2. MS73 and intersegmental muscle cell death in pre-adult 
development 
As noted by Schwartz et al. [19], the ventral abdominal 
intersegmental muscles do not all undergo programmed cell 
death at the same time. While the muscles in abdominal seg-
ments 3-6 (ISM3-6) regress just before adult ecdysis, and then 
degenerate immediately afterwards, the muscles of abdominal 
segments 1 and 2 (ISMI-2), 7 and 8 (ISM7-8), have already 
disappeared long before this time. In these muscles, pro-
grammed cell death is associated with the metamorphic tran-
sition from larva to pupa, occurring just after pupal ecdysis. 
We first established that ISMI-2 and ISM7-8 were present 
at the time of pupal ecdysis (stage PO), but then degenerated 
rapidly, so that by 48 h after ecdysis (stage P2) only very thin 
and fragile fibres remained. By 72 h after ecdysis the muscles 
could no longer be seen. By contrast, ISM3-6 remained un-
changed in appearance during this period. 
MS73 levels were estimated from immunoblots of TBS-sol-
uble protein from ISMI-2, ISM3-6, and ISM7-8 in insects 
undergoing development from feeding fifth stage larva to 
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Fig. 2. MS73 protein in different regions of the abdominal interseg-
mental muscles at different stages of development. A: Immunoblots 
of SDS-polyacrylamide gels. 10 ~g of total TBS-soluble protein was 
loaded in each well. B: Quantitative estimates of the amounts of 
MS73 in each of the tissues obtained from digital images of the 
bands shown in A. ISMI-2 is the intersegmental muscle from ab-
dominal segments I and 2, and so on. The stages shown are LS, 
fifth stage feeding larva about 8 g in weight, about 12 h before 
wandering; WO, fifth stage larva 0-24 h after wandering; PI, pupa 
24-48 h after ecdysis. ISMI-2 and ISM 7-8 are dying at stage PI. 
ISM3-6 survives until adult eclosion, some 21 days later. 
emerged pupa. Fig. 2 shows that the amounts of MS73 pro-
tein in all three muscles of feeding larvae (L5) are similar to 
those in newly wandered larvae (WO, a stage when the larvae 
cease to feed and prepare to pupate). In newly emerged pupae 
(PI, 5 days after wandering), however, all the intersegmental 
muscles show much higher levels of MS73. The increase was 
most marked in the muscles which die at this time, ISMI-2 
and ISM7-8 (increases of 2.8 X and 2.7 X respectively), so 
that in these muscles the intensity of the MS73 bands was 
comparable to that seen in ISM3-6 of pharate adult moths 
just before and after emergence (Fig. 1). ISM3-6, however, 
which does not undergo programmed cell death at this time, 
also showed a clear increase (1.8 X) in the level of MS73, 
although not to the levels seen in muscles that die (ISMI-2, 
7-8). 
3.3. MS73 and cell death in larval pro leg muscles 
Programmed cell death also occurs during metamorphosis 
in other lepidopteran muscles. The degeneration and death of 
the larval pro leg retractor (plantar retractor) muscles (PRM) 
have been previously studied [20] in the wax moth, Galleria 
mellonella, in which the death of these muscles occurs after 
pupal ecdysis. In Manduca, however, we have found that the 
muscles die rather earlier than in Galleria, disappearing during 
the period between wandering and pupal ecdysis (Low and 
Reynolds, unpublished). In Manduca the PRM persisted 
with essentially unaltered appearance until stage W2 (2 days 
after the cessation of feeding), but then degenerated rapidly, 
being represented only in the form of thin, fragile fibres 1 day 
later at stage W3. This change coincided with the start of 
deposition of the new pupal cuticle underneath the old larval 
cuticle, and the loss of mobility of the larval prolegs. 
Immunoblots of TBS-soluble protein from the PRM (Fig. 
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3) showed that MS73 was present at a relatively low level at 
stage WO, before signs of programmed cell death were evident, 
but that the amount of MS73 in the muscle increased mark-
edly on day WI and reached a still higher level on day W2. 
Samples could not be taken at stage W3 because the muscles 
were too delicate to collect. The increase in MS73 from stage 
WO to stage W2 was 2.7 X. The final level of MS73 band 
intensity was comparable to that seen in ISM3-6 at the time 
of adult eclosion. 
3.4. Hormonal manipulation of MS73 levels 
Schwartz and Truman have shown that in Manduca, both 
the pre-eclosion regression and the rapid post-eclosion death 
of the adult insect's ISM3-6 are under the control of the 
ecdysteroid moulting hormone, 20-hydroxyecdysone (20HE) 
[2]. Programmed cell death of these muscles can occur only 
following the normal pre-eclosion decline in titre of this hor-
mone. The administration of exogenous 20HE delays or pre-
vents completely both these processes. Injections of 20HE are 
much less effective than continuous infusion, however, pre-
sumably because the hormone is rapidly degraded in vivo. 
We therefore used a synthetic, non-metabolisable non-ste-
roidal ecdysteroid agonist, RH-5849 [21,22], to test whether 
MS73 expression is regulated by ecdysteroid action in the 
same way as is cell death. We found that a single injection 
of 10 !lg RH-5849 given to stage 3 pharate adult insects com-
pletely prevented both adult eclosion and the degeneration of 
ISM3-6. This treatment also prevented the normally occur-
ring increase in level of MS73 in ISM3-6 (Fig. 4A), support-
ing the hypothesis that this proteasome subunit is in some 
way involved with programmed cell death. 
Injection of RH-5849 (10 !lg) into earlier stages of Manduca 
had different effects on programmed muscle cell death accord-
ing to the stage that was injected and the muscles concerned. 
When the ecdysteroid agonist was given to feeding larvae just 
prior to wandering, the increase in MS73 level normally seen 
in PRM 2 days later was completely prevented, as was pro-
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Fig. 3. MS73 protein in proleg retractor muscle (PRM). A: Immu-
noblots of SDS-polyacrylamide gels. 10 ~g of total TBS-soluble pro-
tein was loaded in each well. B: Quantitative estimates of the 
amounts of MS73 in each of the tissues obtained from digital 
images of the bands shown in A. The stages shown are WO, WI 
and W2, which are fifth stage larvae 0-24, 24-48 and 48-72 h after 
wandering respectively. 
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Fig. 4. Effect of RH-5849 on MS73 protein levels in three different muscles. A: ISM3-6. RH-5849 (10 llg) was given at stage 3. This treatment 
arrested pharate adult development and prevented eclosion. Samples were taken when controls (injected with vehicle) had reached stage 8. 
B: ISMl-2 and ISM7-8. RH-5849 (10 llg) was given at stage W2. This treatment prevented pupal ecdysis. Samples were taken after 72 h when 
controls had successfully shed the larval cuticle (i.e. were PO). C: PRM. RH-5849 (10 llg) was given to day 4 fifth ins tar feeding larvae (i.e. on 
the day before wandering). This treatment did not prevent wandering. Samples were taken after 24 h, i.e. on day WOo 
grammed death of that muscle (Fig. 4C). By contrast, the 
effect of RH-5849 on ISMI-2 and 7-8 was quite different. 
As shown above, these muscles normally degenerate during 
the 72 h following pupal ecdysis, expressing MS73 at a high 
level on day PO. When RH-5849 (10 Ilg) was given on day 
W2, the treatment prevented the occurrence of pupal ecdysis, 
as would be expected from the similar effect of 20HE [2]. 
Despite this, the hormone agonist had no effect on either 
the programmed death of ISMI-2 and ISM 7-8 (which 
took place on time, as though pupal ecdysis had taken place) 
nor on the level of MS73 in these muscles, measured after 3 
days when the controls had reached stage PO (Fig. 4B). This 
suggests that in the case of ISMI-2 and ISM 7-8, pro-
grammed cell death is not dependent on a normally occurring 
decline in ecdysteroid titre. All the experimental results are 
however consistent with a role for MS73 in the cell death 
process. Interestingly, however, the treated insects did show 
a reduction in the level of MS73 present in ISM3-6 (Fig. 4B). 
Clearly this effect of RH-5849 is not directly related to cell 
death, since this muscle does not die at this time in either the 
controls or the treated insects. 
4. Discussion 
MS73 is a subunit of the 26S proteasome in the insect 
Manduca sexta. It has sequence similarity to proteasome reg-
ulatory A TPases from other organisms, in particular S6 in 
mammalian proteasomes and YT A2 in yeast, and may be 
presumed to have a similar regulatory role in Manduca [3]. 
We have shown here that MS73 is differentially expressed in a 
variety of cell types and at different times. It is evident that 
MS73 is found at high level only in body wall muscles that are 
undergoing or are destined to undergo programmed cell 
death. 
MS73 was identified from a eDNA clone, the library being 
obtained from late pharate adult abdominal intersegmental 
muscle (ISM3-6), a tissue which degenerates around this 
time. The mRNA from which the library was constructed 
was taken from ISM3-6 at a time when it was about to under-
go programmed death. MS73 immunoreactivity has now been 
found to be present in two other muscle types that undergo 
developmentally programmed death, the intersegmental mus-
cles ISMI-2 and ISM 7-8, which die just after pupal ecdysis, 
and the proleg retractor muscle (PRM), which dies just before 
pupal ecdysis. In all three muscle types, the level of MS73 
more than doubles just before death occurs. The amount of 
MS73 in these muscles at this time, relative to total TBS-
soluble protein, was with a single exception more than twice 
that seen in any other tissue at any time. This suggests that 
MS73 may be involved in the cellular processes that lead to 
programmed death. The single exception will be discussed 
further below. 
Treatment of insects with RH-5849, an ecdysteroid agonist, 
had different effects on different muscles, presumably accord-
ing to the mechanism whereby programmed muscle cell death 
is regulated. In the case of ISM3-6 and PRM, treatment with 
RH-5849 prevented both cell death and the accompanying rise 
in MS73 level. Death of ISM3-6 is known [2] to be dependent 
on the decline in ecdysteroid titre which normally occurs be-
fore adult eclosion, and the repression of both celI death and 
MS73 expression in this muscle by RH-5849 is in accord with 
this. The similar effect of RH-5849 on PRM suggests that in 
this muscle too, programmed death is dependent on a falling 
ecdysteroid titre. By contrast, RH-5849 failed to prevent cell 
death in ISMI-2 and ISM7-8, and also did not prevent the 
associated rise in MS73 level. This implies that in this muscle 
cell type, death is not regulated by the falling ecdysteroid titre, 
and that in these celIs MS73 expression is regulated by other 
factors. 
The single exception to the general pattern of results dis-
cussed above is that in which MS73 levels were found to be 
high in ISM3-6 just after pupal ecdysis (although not as high 
as in dying muscles). This is a problem for the hypothesis that 
MS73 plays an obligatory and causal role in programmed 
muscle celI death. This muscle type undergoes programmed 
death, and does so at a time (adult eclosion) when MS73 
levels are high, but the earlier post-pupal ecdysis rise in 
MS73 level does not lead to the death of ISM3-6 at this 
time. Thus if MS73 is indeed involved in the machinery of 
programmed cell death, elevated expression of MS73 alone is 
not sufficient to ensure that death ensues. It could be that the 
lack of some other factor, perhaps another regulatory protea-
P. Low et al.lFEBS Letters 400 (1997) 345-349 
some subunit, that prevents death. Alternatively, it is possible 
that the level of MS73 needs to pass some critical threshold 
which is not exceeded in ISM3-6 at stage Pl. 
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